Ultrasonographic Assessment of Carpal Tunnel Syndrome in Children With Mucopolysaccharidosis and Comparison to Median Nerve Anatomy in Healthy Children.
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 44
- 试验地点
- 1
- 主要终点
- Median nerve cross-sectional area in children with mucopolysaccharidosis and a cohort of healthy children, ages 3-12.
研究概览
简要总结
Mucopolysaccharidosis are lysosomal storage disorders such as Hunter, Hurler, and Sanfilippo syndromes. These patients have a genetic enzyme deficiency that results in the inability to degrade glycosaminoglycans. The glycosaminoglycans accumulate in lysosomes causing cell enlargement and subsequent dysfunction. The accumulation occurs in all tissues including cartilage, joint capsule, and tendons and can lead to carpal tunnel syndrome, trigger digits, and various other orthopaedic manifestations [Van Heest, White]. These children often suffer from severe cognitive impairment and are often unable to communicate pain or numbness. Carpal tunnel syndrome is almost always present, but may not become apparent until symptoms are severe and loss of function has occurred. The current gold standard for diagnosis consists of electromyographic (EMG) and nerve conduction velocity (NCV) studies under sedation or general anesthetic [Khanna].
Primary Objective: The investigators plan to correlate EMG findings and median nerve cross-sectional area in children with mucopolysaccharidosis. The investigators hypothesis is that ultrasonography of the carpal tunnel in patients with mucopolysaccharidosis will prove to be an effective, reliable, and safe method to evaluate the median nerve, thus avoiding the need for EMG studies and anesthesia.
Secondary Objective: The investigators want to determine the cross-sectional area of the median nerve using ultrasonography in a cohort of healthy children, ages 3-12. The investigators plan to evaluate a cohort of healthy children to determine a normal cross-sectional area of the median nerve.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 3 Years 至 12 Years(Child)
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •For the first arm of the study (25 participants):
- •Children with mucopolysaccharidosis presenting to the senior author's clinic with signs or symptoms of carpal tunnel syndrome will be enrolled to receive both an EMG and carpal tunnel ultrasound of the upper extremities.
- •For the second arm of the study (100 participants):
- •Healthy children ages 3-12 with no acute upper extremity trauma or history of mucopolysaccharidosis.
- •25 additional participants requested in case of inconclusive ultrasound results, patient removal, or other unusable results.
排除标准
- •Children with mucopolysaccharidosis who have undergone previous treatment for carpal tunnel syndrome.
- •Second arm:
- •Acute (<3month) wrist or hand surgery/injuries.
- •Unable to obtain parental consent or patient assent.
- •History of mucopolysaccharidosis.
- •Non-english speaking.
- •Cognitive impairment.
结局指标
主要结局
Median nerve cross-sectional area in children with mucopolysaccharidosis and a cohort of healthy children, ages 3-12.
时间窗: 6-weeks after open carpal tunnel release
次要结局
未报告次要终点
研究者
Douglas Hutchinson
M.D.
University of Utah
